Table 3.
Multivariate analysis for overall survival (OS) of stage IIIC patients with endometrial cancer.
| Variables | Stage IIIC1 | Stage IIIC2 | ||
|---|---|---|---|---|
| HR (95% CI) | P | HR (95% CI) | P | |
| Age, yrs | ||||
| 18–60 | Reference | Reference | ||
| >60 | 1.579 (1.375–1.814) | <0.001 | 1.481 (1.255–1.748) | <0.001 |
| Race | ||||
| White | Reference | Reference | ||
| Black | 1.310 (1.117–1.537) | 0.001 | 1.156 (0.955–1.400) | 0.136 |
| Others | 0.754 (0.590–0.963) | 0.024 | 0.896 (0.700–1.147) | 0.383 |
| Marital status | ||||
| Married | Reference | Reference | ||
| Others | 1.303 (1.145–1.484) | <0.001 | 1.366 (1.171–1.593) | <0.001 |
| Grade | ||||
| I+II | Reference | Reference | ||
| III+IV | 2.528 (2.143–2.983) | <0.001 | 2.555 (2.040–3.200) | <0.001 |
| Others | 1.809 (1.491–2.195) | <0.001 | 1.884 (1.452–2.446) | <0.001 |
| Histology | ||||
| Endometrioid | Reference | Reference | ||
| Serous | 1.406 (1.167–1.694) | <0.001 | 1.394 (1.128–1.722) | <0.001 |
| Others | 1.883 (1.637–2.166) | <0.001 | 1.459 (1.217–1.749) | <0.001 |
| Chemotherapy | ||||
| Yes | Reference | Reference | ||
| No/unknown | 1.446 (1.287–1.670) | <0.001 | 1.581 (1.350–1.853) | <0.001 |
| Radiotherapy | ||||
| Yes | Reference | Reference | ||
| No/unknown | 1.526 (1.336–1.743) | <0.001 | 1.376 (1.170–1.619) | <0.001 |